🟢 Indaptus Therapeutics is trading 5% up in pre-market — no company-specific catalyst identified

Indaptus Therapeutics is trading at $3.32, up 5.06% in pre-market, with no identified company-specific announcement explaining the move.

• No new company-specific announcement explaining the October 22 pre-market move was identified.
• A recent $24 million private placement was reported as completed October 16, but available reporting does not link it directly to this morning’s move.
• Biotech was up 3.64% pre-market, which may support the move; major U.S. indices were lower, so the broader market is not a clear explanation.